• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

即时检测微流控芯片电泳用于贫血症和血红蛋白变异体的综合检测。

Point-of-care microchip electrophoresis for integrated anemia and hemoglobin variant testing.

机构信息

Department of Mechanical and Aerospace Engineering, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA.

Department of Physics, Case Western Reserve University, Cleveland, OH 44106, USA.

出版信息

Lab Chip. 2021 Oct 12;21(20):3863-3875. doi: 10.1039/d1lc00371b.

DOI:10.1039/d1lc00371b
PMID:34585199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9714341/
Abstract

Anemia affects over 25% of the world's population with the heaviest burden borne by women and children. Genetic hemoglobin (Hb) variants, such as sickle cell disease, are among the major causes of anemia. Anemia and Hb variant are pathologically interrelated and have an overlapping geographical distribution. We present the first point-of-care (POC) platform to perform both anemia detection and Hb variant identification, using a single paper-based electrophoresis test. Feasibility of this new integrated diagnostic approach is demonstrated testing individuals with anemia and/or sickle cell disease. Hemoglobin level determination is performed by an artificial neural network (ANN) based machine learning algorithm, which achieves a mean absolute error of 0.55 g dL and a bias of -0.10 g dL against the gold standard (95% limits of agreement: 1.5 g dL) from Bland-Altman analysis on the test set. Resultant anemia detection is achieved with 100% sensitivity and 92.3% specificity. With the same tests, subjects with sickle cell disease were identified with 100% sensitivity and specificity. Overall, the presented platform enabled, for the first time, integrated anemia detection and hemoglobin variant identification using a single point-of-care test.

摘要

贫血影响着全球超过 25%的人口,其中妇女和儿童所受影响最为严重。遗传性血红蛋白(Hb)变体,如镰状细胞病,是贫血的主要原因之一。贫血和 Hb 变体在病理上相互关联,且具有重叠的地理分布。我们首次提出了一种即时检测(POC)平台,可同时进行贫血检测和 Hb 变体识别,使用的是单一基于纸质的电泳测试。通过对患有贫血症和/或镰状细胞病的个体进行测试,验证了这种新的集成诊断方法的可行性。血红蛋白水平的测定是通过基于人工神经网络(ANN)的机器学习算法进行的,该算法在测试集上的 Bland-Altman 分析中实现了 0.55g/dL 的平均绝对误差和 0.10g/dL 的偏差(95%一致性界限:1.5g/dL)。由此得出的贫血检测结果具有 100%的灵敏度和 92.3%的特异性。使用相同的测试,镰状细胞病患者的识别具有 100%的灵敏度和特异性。总的来说,该平台首次实现了使用单一即时检测来进行集成的贫血检测和血红蛋白变体识别。

相似文献

1
Point-of-care microchip electrophoresis for integrated anemia and hemoglobin variant testing.即时检测微流控芯片电泳用于贫血症和血红蛋白变异体的综合检测。
Lab Chip. 2021 Oct 12;21(20):3863-3875. doi: 10.1039/d1lc00371b.
2
Paper-based microchip electrophoresis for point-of-care hemoglobin testing.基于纸的微流控芯片电泳用于即时血红蛋白检测。
Analyst. 2020 Apr 7;145(7):2525-2542. doi: 10.1039/c9an02250c. Epub 2020 Mar 3.
3
Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.坦桑尼亚贫血和镰状细胞病的即时检测:RAPID研究
Ann Hematol. 2018 Feb;97(2):239-246. doi: 10.1007/s00277-017-3182-8. Epub 2017 Nov 16.
4
Non-invasive hemoglobin measurement devices require refinement to match diagnostic performance with their high level of usability and acceptability.非侵入式血红蛋白测量设备需要进一步改进,以使其诊断性能与其高度的可用性和可接受性相匹配。
PLoS One. 2021 Jul 16;16(7):e0254629. doi: 10.1371/journal.pone.0254629. eCollection 2021.
5
Accuracy of Point-of-Care Testing for Anemia in the Emergency Department.急诊科即时检验贫血的准确性。
Respir Care. 2019 Nov;64(11):1343-1350. doi: 10.4187/respcare.06364. Epub 2019 Mar 26.
6
Accuracy of anemia screening by point-of-care hemoglobin testing in patients seeking abortion.在寻求堕胎的患者中,即时血红蛋白检测进行贫血筛查的准确性。
Contraception. 2022 Jan;105:51-54. doi: 10.1016/j.contraception.2021.09.003. Epub 2021 Sep 10.
7
Comparability of Point-of-Care versus Central Laboratory Hemoglobin Determination in Emergency Patients at a Supra-Maximal Care Hospital.超大型急救医院急诊患者即时检测与中心实验室血红蛋白测定的可比性
PLoS One. 2016 Nov 23;11(11):e0166521. doi: 10.1371/journal.pone.0166521. eCollection 2016.
8
A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.一种使用新型、高度特异性单克隆抗体的用于镰状细胞病的快速、廉价且一次性即时检测血液测试。
Br J Haematol. 2016 Nov;175(4):724-732. doi: 10.1111/bjh.14298. Epub 2016 Sep 8.
9
Evaluation of point-of-care testing device for anemia detection: A cross-sectional method comparison study from Thailand.贫血检测即时检验设备的评估:来自泰国的横断面方法比较研究。
J Clin Lab Anal. 2021 Oct;35(10):e23976. doi: 10.1002/jcla.23976. Epub 2021 Aug 24.
10
A portable smartphone-based hemoglobin point-of-care testing platform for accurate anemia diagnostics.一种基于智能手机的便携式即时血红蛋白检测平台,可实现精准的贫血诊断。
Biosens Bioelectron. 2022 Dec 1;217:114711. doi: 10.1016/j.bios.2022.114711. Epub 2022 Sep 11.

引用本文的文献

1
Demonstrating public health impacts of translational science at the clinical and translational science collaborative (CTSC) of northern Ohio: a mixed-methods approach using the translational science benefits model.在俄亥俄州北部临床与转化科学协作中心(CTSC)展示转化科学对公共卫生的影响:采用转化科学效益模型的混合方法。
Front Public Health. 2025 Aug 13;13:1560751. doi: 10.3389/fpubh.2025.1560751. eCollection 2025.
2
Emerging Technologies and Advanced Strategies in Hemoglobin Defect Screening.血红蛋白缺陷筛查中的新兴技术与先进策略
J Clin Med. 2025 Aug 12;14(16):5690. doi: 10.3390/jcm14165690.
3
A multiplexed, allele-specific recombinase polymerase amplification assay with lateral flow readout for sickle cell disease detection.一种多重、等位基因特异性重组酶聚合酶扩增检测方法,具有侧流读取功能,用于检测镰状细胞病。
Lab Chip. 2024 Aug 20;24(17):4115-4127. doi: 10.1039/d4lc00281d.
4
Differential sensitivity to hypoxia enables shape-based classification of sickle cell disease and trait blood samples at point of care.对缺氧的差异敏感性使得在护理点能够基于形状对镰状细胞病和特征血样进行分类。
Bioeng Transl Med. 2023 Dec 27;9(4):e10643. doi: 10.1002/btm2.10643. eCollection 2024 Jul.
5
Metabolite and protein shifts in mature erythrocyte under hypoxia.缺氧条件下成熟红细胞中的代谢物和蛋白质变化
iScience. 2024 Feb 23;27(4):109315. doi: 10.1016/j.isci.2024.109315. eCollection 2024 Apr 19.
6
Point-of-Care Diagnostic Test for Beta-Thalassemia.即时检测β-地中海贫血症
Biosensors (Basel). 2024 Feb 2;14(2):83. doi: 10.3390/bios14020083.
7
A pH-mediated field amplification sample stacking technique based on portable microchip electrophoresis heavy metal ion detection system.一种基于便携式微芯片电泳重金属离子检测系统的pH介导场放大样品堆积技术。
Anal Sci. 2023 Sep;39(9):1475-1482. doi: 10.1007/s44211-023-00364-y. Epub 2023 May 20.
8
Catch bonds in sickle cell disease: Shear-enhanced adhesion of red blood cells to laminin.镰状细胞病中的捕获键:层粘连蛋白增强红细胞与剪切力的黏附。
Biophys J. 2023 Jun 20;122(12):2564-2576. doi: 10.1016/j.bpj.2023.05.010. Epub 2023 May 12.
9
Artificial Intelligence in Point-of-Care Testing.即时检验中的人工智能。
Ann Lab Med. 2023 Sep 1;43(5):401-407. doi: 10.3343/alm.2023.43.5.401. Epub 2023 Apr 21.
10
Last Trends in Point-of-Care (POC) Diagnostics for the Management of Hematological Indices in Home Care Patients.居家患者血液学指标的即时检验(POC)诊断管理的最新趋势。
Biosensors (Basel). 2023 Mar 4;13(3):345. doi: 10.3390/bios13030345.

本文引用的文献

1
AI-Enabled Wearable and Flexible Electronics for Assessing Full Personal Exposures.用于评估个人全面暴露情况的人工智能可穿戴及柔性电子产品。
Innovation (Camb). 2020 Aug 5;1(2):100031. doi: 10.1016/j.xinn.2020.100031. eCollection 2020 Aug 28.
2
Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage.在血液短缺期间需要进行红细胞交换的镰状细胞病患者减少红细胞使用的措施。
Blood Adv. 2021 Jun 22;5(12):2586-2592. doi: 10.1182/bloodadvances.2021004395.
3
Techniques for the Detection of Sickle Cell Disease: A Review.镰状细胞病的检测技术:综述
Micromachines (Basel). 2021 May 5;12(5):519. doi: 10.3390/mi12050519.
4
Emerging point-of-care technologies for anemia detection.用于贫血检测的新兴即时检测技术。
Lab Chip. 2021 May 18;21(10):1843-1865. doi: 10.1039/d0lc01235a.
5
AnemoCheck-LRS: an optimized, color-based point-of-care test to identify severe anemia in limited-resource settings.AnemoCheck-LRS:一种优化的、基于颜色的即时检测方法,用于在资源有限的环境中识别严重贫血。
BMC Med. 2020 Nov 16;18(1):337. doi: 10.1186/s12916-020-01793-6.
6
Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa.撒哈拉以南非洲地区镰状细胞贫血的羟脲剂量升级。
N Engl J Med. 2020 Jun 25;382(26):2524-2533. doi: 10.1056/NEJMoa2000146.
7
A Portable Smartphone-linked Device for Direct, Rapid and Chemical-Free Hemoglobin Assay.一种便携式智能手机连接设备,可直接、快速、无需化学试剂进行血红蛋白检测。
Sci Rep. 2020 May 25;10(1):8606. doi: 10.1038/s41598-020-65607-8.
8
Paper-based microchip electrophoresis for point-of-care hemoglobin testing.基于纸的微流控芯片电泳用于即时血红蛋白检测。
Analyst. 2020 Apr 7;145(7):2525-2542. doi: 10.1039/c9an02250c. Epub 2020 Mar 3.
9
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.美国血液学会 2020 年镰状细胞病指南:输血支持。
Blood Adv. 2020 Jan 28;4(2):327-355. doi: 10.1182/bloodadvances.2019001143.
10
Sickle cell disease: current treatment and emerging therapies.镰状细胞病:当前的治疗方法与新兴疗法
Am J Manag Care. 2019 Nov;25(18 Suppl):S335-S343.